ArticleJOR spine2024
Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration.
Graham Hagger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it